SK Biopharm Decides to Sell 22.06 Million Shares of Abel Therapeutics
[Asia Economy Reporter Park Jun-yi] SK Biopharm announced on the 4th that it has decided to sell 22,059,039 shares of Dutch pharmaceutical company Arvelle Therapeutics B.V. to Italian pharmaceutical company Angelini Pharma S.p.A. The transfer amount is approximately 35.14703 billion KRW. The scheduled transfer date is March 31. SK Biopharm explained, "We intend to utilize the secured capital gains to execute our growth strategy."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Samsung Labor-Management 'Performance Bonus Negotiations' Fail in Third Mediation... Union Says "General Strike to Proceed as Planned Tomorrow"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
